My ePortfolio Register   

Abstract | Full HTML Article | PDF ecancer 12 813 /

Conference Report

Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017, Charité, Berlin

Acetylsalicylic acid was first synthesised by Dr FeIix Hoffman on 10th August 1897 and Aspirin was born. It quickly became the best-known pain killer in the world and in the 120 years since this event, aspirin has continued to attract interest, innovation and excitement. Set within the walls of the preserved ruins of Rudolf Virchow’s lecture hall at Charité, within Berlin’s Museum of Medical History, the International Aspirin Foundation’s 28th Scientific Conference served to facilitate international, multi-disease, multidisciplinary discussion about the current understanding of aspirin’s mechanisms of action and its utility in modern medicine as well as ideas for future research into its multifaceted applications to enhance global health.

Keywords: aspirin, inflammation, primary prevention, secondary prevention, tertiary prevention, colorectal cancer (CRC), cardiovascular disease (CVD), stroke, bleeding, risk, benefit, Lynch syndrome, precision medicine, individualised choice, personalised medicine


Drug development

Loading Article Metrics ... Please wait

Related videos

Related articles

Clinical Study: Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents

Abstract | Full Article | PDF Published: 23 Nov 2017 /

Conference Report: Highlights from the WIN 2017 Symposium, 26–27 June 2017, Paris, France: ‘Expediting Global Innovation in Precision Cancer Medicine’

Abstract | Full Article | PDF Published: 27 Sep 2017 /

Conference Report: Next generation metronomic chemotherapy—report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6–8 May 2016, Mumbai

Abstract | Full Article | PDF Published: 02 Nov 2016 /

Clinical Study: Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent

Abstract | Full Article | PDF Published: 12 Oct 2016 /

Conference Report: Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina

Abstract | Full Article | PDF | Spanish Published: 06 Sep 2016 /

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence